We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
- Authors
Friedberg, J W; Neuberg, D; Stone, R M; Alyea, E; Jallow, H; LaCasce, A; Mauch, P M; Gribben, J G; Ritz, J; Nadler, L M; Soiffer, R J; Freedman, A S
- Abstract
The absolute risk of myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for non-Hodgkin's lymphoma (NHL) exceeds 5% in several reported series. We report the outcome of a large cohort of patients who developed MDS after ABMT for NHL.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Vol 17, Issue 10, p3128
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1999.17.10.3128